Literature DB >> 30063913

Community-acquired group B streptococcal meningitis in adults: 33 cases from prospective cohort studies.

Merel N van Kassel1, Merijn W Bijlsma1, Matthijs C Brouwer1, Arie van der Ende2, Diederik van de Beek3.   

Abstract

OBJECTIVES: Streptococcus agalactiae (group B streptococcus, GBS) is an uncommon cause of bacterial meningitis in adults. We describe clinical characteristics, serotype distribution and outcome of adult GBS meningitis. PATIENTS AND METHODS: Patients aged 16 years or older with GBS cultured in cerebrospinal fluid included in two prospective nationwide cohort studies performed in the Netherlands between 1998-2002 and 2006-2017 were evaluated.
RESULTS: We identified 33 patients with GBS meningitis with a median age of 58 years of whom 22 were male (67%). The mean annual incidence was .16 per 1.000.000 adults. Ten patients (30%) had an immunocompromised state, which was due to alcoholism in 6 (18%) and diabetes mellitus in 4 (12%). Eleven patients (33%) had a distant focus of infection of whom 4 had endocarditis (13%). Seven patients (21%) died and 6 (18%) survivors had sequelae causing disability, including reduced vision and blindness due to endophthalmitis (n = 2). Twenty patients (61%) made a full recovery. Most common bacterial serotypes were serotype III (41%) and Ia (25%). Serotype V was associated with increased mortality (3 of 4 [75%] serotype V died vs. 4 of 28 [14%] other serotypes, P = .025).
CONCLUSION: GBS is a rare cause of meningitis in adults that more frequently occurs in patients with underlying comorbidities. Patients should be carefully evaluated for distant foci of infection. GBS serotype V is associated with poor outcome.
Copyright © 2018 The British Infection Association. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bacterial Meningitis; Bacterial infections; Group B Streptococcus; Meningitis; Neurology; Streptococcus Agalactiae

Mesh:

Year:  2018        PMID: 30063913     DOI: 10.1016/j.jinf.2018.07.009

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  6 in total

1.  Community-acquired meningitis caused by beta-haemolytic streptococci in adults: a nationwide population-based cohort study.

Authors:  Nicolai Kjærgaard; Jacob Bodilsen; Ulrik Stenz Justesen; Henrik Carl Schønheyder; Christian Østergaard Andersen; Svend Ellermann-Eriksen; Esad Dzajic; Ming Chen; Jens Kjølseth Møller; Ram Benny Dessau; Niels Frimodt-Møller; Jens Otto Jarløv; Henrik Nielsen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-08-22       Impact factor: 3.267

2.  CC17 group B Streptococcus exploits integrins for neonatal meningitis development.

Authors:  Romain Deshayes de Cambronne; Agnès Fouet; Amandine Picart; Anne-Sophie Bourrel; Cyril Anjou; Guillaume Bouvier; Cristina Candeias; Abdelouhab Bouaboud; Lionel Costa; Anne-Cécile Boulay; Martine Cohen-Salmon; Isabelle Plu; Caroline Rambaud; Eva Faurobert; Corinne Albigès-Rizo; Asmaa Tazi; Claire Poyart; Julie Guignot
Journal:  J Clin Invest       Date:  2021-03-01       Impact factor: 14.808

3.  Erythrocyte-Coated Nanoparticles Block Cytotoxic Effects of Group B Streptococcus β-Hemolysin/Cytolysin.

Authors:  Jenny Koo; Tamara Escajadillo; Liangfang Zhang; Victor Nizet; Shelley M Lawrence
Journal:  Front Pediatr       Date:  2019-11-01       Impact factor: 3.418

Review 4.  Phage therapy as a revolutionary medicine against Gram-positive bacterial infections.

Authors:  Archana Loganathan; Prasanth Manohar; Kandasamy Eniyan; C S VinodKumar; Sebastian Leptihn; Ramesh Nachimuthu
Journal:  Beni Suef Univ J Basic Appl Sci       Date:  2021-08-28

5.  Mast cell-derived factor XIIIA contributes to sexual dimorphic defense against group B streptococcal infections.

Authors:  Adrian M Piliponsky; Kavita Sharma; Phoenicia Quach; Alyssa Brokaw; Shayla Nguyen; Austyn Orvis; Siddhartha S Saha; Nyssa Becker Samanas; Ravin Seepersaud; Yu Ping Tang; Emily Mackey; Gauri Bhise; Claire Gendrin; Anna Furuta; Albert J Seo; Eric Guga; Irina Miralda; Michelle Coleman; Erin L Sweeney; Charlotte A Bäuml; Diana Imhof; Jessica M Snyder; Adam J Moeser; Lakshmi Rajagopal
Journal:  J Clin Invest       Date:  2022-10-17       Impact factor: 19.456

6.  Cas9 Contributes to Group B Streptococcal Colonization and Disease.

Authors:  Brady L Spencer; Liwen Deng; Kathryn A Patras; Zachary M Burcham; Glenda F Sanches; Prescilla E Nagao; Kelly S Doran
Journal:  Front Microbiol       Date:  2019-08-21       Impact factor: 5.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.